Asset Detail: Outlook Therapeutics stock undergoes 1-for-20 reverse stock split
Asset Information
Source Context: This media is attached to the document Outlook Therapeutics Stock.
Usage: Authorized for internal review, study guides, and academic presentations. Please cite the original document when embedding this asset.